Tactiva Therapeutics Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$35M
- Investors
-
7
Tactiva Therapeutics General Information
Description
Operator of an immuno-oncology company intended to specialize in potent cancer immunotherapy using a dual T cell receptor approach. The company's platform consists of engineered cells that generate a durable supply of cells with direct anti-tumor activity as well as a sustained helper function to cell-derived transduced effector T cells, enabling doctors and medical professionals to diagnose and treat life-threatening diseases effectively.
Contact Information
Website
www.tactivatherapeutics.comCorporate Office
- 701 Ellicott Street, 4th Floor
- Buffalo, NY 14203
- United States
Corporate Office
- 701 Ellicott Street, 4th Floor
- Buffalo, NY 14203
- United States
Tactiva Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC (Series A) | 01-Nov-2018 | $35M | Completed | Pre-Clinical Trials | ||
| 3. Grant | Completed | Pre-Clinical Trials | ||||
| 2. Accelerator/Incubator | 27-Feb-2017 | $1.1M | $2.6M | Completed | Pre-Clinical Trials | |
| 1. Seed Round | 01-Jul-2016 | $1.5M | $1.5M | Completed | Startup |
Tactiva Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A1 | ||||||||
| Series A |
Tactiva Therapeutics Signals
Tactiva Therapeutics Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Panacea Capital (California) | Venture Capital | Minority | ||
| Shenzhen Yifeng Investment Management Enterprise | Venture Capital | Minority | ||
| VI Ventures | Venture Capital | Minority | ||
| Start-up NY | Accelerator/Incubator | Minority | ||
| Angel (individual) |
Tactiva Therapeutics FAQs
-
When was Tactiva Therapeutics founded?
Tactiva Therapeutics was founded in 2016.
-
Where is Tactiva Therapeutics headquartered?
Tactiva Therapeutics is headquartered in Buffalo, NY.
-
What is the size of Tactiva Therapeutics?
Tactiva Therapeutics has 4 total employees.
-
What industry is Tactiva Therapeutics in?
Tactiva Therapeutics’s primary industry is Drug Discovery.
-
Is Tactiva Therapeutics a private or public company?
Tactiva Therapeutics is a Private company.
-
What is the current valuation of Tactiva Therapeutics?
The current valuation of Tactiva Therapeutics is .
-
What is Tactiva Therapeutics’s current revenue?
The current revenue for Tactiva Therapeutics is .
-
How much funding has Tactiva Therapeutics raised over time?
Tactiva Therapeutics has raised $37.6M.
-
Who are Tactiva Therapeutics’s investors?
Panacea Capital (California), Shenzhen Yifeng Investment Management Enterprise, VI Ventures, Start-up NY, and are 5 of 7 investors who have invested in Tactiva Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process